Focused Wealth Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-33
| Closed | -$2K | – | 1044 |
|
2021
Q2 | $2K | Hold |
33
| – | – | ﹤0.01% | 772 |
|
2021
Q1 | $2K | Hold |
33
| – | – | ﹤0.01% | 758 |
|
2020
Q4 | $2K | Hold |
33
| – | – | ﹤0.01% | 713 |
|
2020
Q3 | $2K | Hold |
33
| – | – | ﹤0.01% | 662 |
|
2020
Q2 | $2K | Hold |
33
| – | – | ﹤0.01% | 647 |
|
2020
Q1 | $2K | Hold |
33
| – | – | ﹤0.01% | 607 |
|
2019
Q4 | $3K | Hold |
33
| – | – | ﹤0.01% | 606 |
|
2019
Q3 | $2K | Hold |
33
| – | – | ﹤0.01% | 623 |
|
2019
Q2 | $3K | Hold |
33
| – | – | ﹤0.01% | 624 |
|
2019
Q1 | $4K | Hold |
33
| – | – | ﹤0.01% | 563 |
|
2018
Q4 | $3K | Hold |
33
| – | – | ﹤0.01% | 585 |
|
2018
Q3 | $3K | Hold |
33
| – | – | ﹤0.01% | 551 |
|
2018
Q2 | $4K | Hold |
33
| – | – | ﹤0.01% | 530 |
|
2018
Q1 | $3K | Hold |
33
| – | – | ﹤0.01% | 589 |
|
2017
Q4 | $3K | Sell |
33
-33
| -50% | -$3K | ﹤0.01% | 589 |
|
2017
Q3 | $7K | Buy |
66
+33
| +100% | +$3.5K | ﹤0.01% | 471 |
|
2017
Q2 | $4K | Hold |
33
| – | – | ﹤0.01% | 578 |
|
2017
Q1 | $4K | Hold |
33
| – | – | ﹤0.01% | 565 |
|
2016
Q4 | $3K | Hold |
33
| – | – | ﹤0.01% | 591 |
|
2016
Q3 | $4K | Hold |
33
| – | – | ﹤0.01% | 560 |
|
2016
Q2 | $5K | Hold |
33
| – | – | ﹤0.01% | 529 |
|
2016
Q1 | $5K | Sell |
33
-60
| -65% | -$9.09K | ﹤0.01% | 487 |
|
2015
Q4 | $14K | Hold |
93
| – | – | 0.01% | 363 |
|
2015
Q3 | $13K | Buy |
93
+33
| +55% | +$4.61K | 0.01% | 359 |
|
2015
Q2 | $9K | Sell |
60
-33
| -35% | -$4.95K | 0.01% | 427 |
|
2015
Q1 | $13K | Hold |
93
| – | – | 0.01% | 386 |
|
2014
Q4 | $14K | Hold |
93
| – | – | 0.01% | 365 |
|
2014
Q3 | $14K | Sell |
93
-40
| -30% | -$6.02K | 0.01% | 376 |
|
2014
Q2 | $19K | Hold |
133
| – | – | 0.01% | 319 |
|
2014
Q1 | $15K | Hold |
133
| – | – | 0.01% | 334 |
|
2013
Q4 | $13K | Buy |
133
+33
| +33% | +$3.23K | 0.01% | 356 |
|
2013
Q3 | $8K | Buy |
+100
| New | +$8K | 0.01% | 396 |
|